Tokyo Growth Machine© March 23-26

Tokyo Growth Machine©**, Powered by mHealth Israel**

Interview and approval required. This is for Series A / B (and beyond) biotech and medical device companies that have raised at least $10m with traction in either the US or Israel. Time in Tokyo is dedicated to meetings with Japanese corporates and investors. To arrange an interview, contact horigome.mihoko.0318@gmail.com

Application Deadline: Feb 10th
Eligibility: Series A / B Israeli biotech and medical device companies, with at least $10m raised in equity / grants
Online Program (Feb 24-March 17):
- Pre-visit: 4 online sessions focused on Japan Healthcare market
Online Sessions:
• Market Overview
• NHI Pricing & Reimbursement
• Regulatory Pathways & Market Access
• Provider Landscape & Care Delivery Models
• Pharmaceutical Market Dynamics
• MedTech & Diagnostics Market Overview
• Long‑Term Care & Elderly Care Market
• Commercial Strategy & Go‑to‑Market Models
• Competitive Landscape & Case Studies
• Working with Japanese Corporates
• Negotiation in a Japanese context

Tokyo Schedule (March 23-26):
- 20 Japanese corporates (half pharma, half medical device)
- 15 Japan-based healthtech investors
- 3 relevant government agencies
Accommodations (paid by attendees): 5 star Sheraton / Miyako. JPY 23,000 (double occupancy); JPY 21,000 (single occupancy

Background: Systematic program for ultra-high potential, market-ready, Series A / B Israeli founded biotech and medical device companies.

Why: Japan is the world #4 healthcare market. Unfortunately, Israel ranks #40 among countries exporting to Japan. The Tokyo Growth Machine© combines systematic preparation with a robust network of relationships and track record securing local partnerships.

Mentors: 20 Tokyo-based mentors spanning regulatory, finance, technology, investment and other key sectors. This group can provide valuable insights and introductions.

Past Results: This team has an unrivaled track record of bridging Israel / Japan and securing corporate partnerships on behalf of Israeli HealthTech companies.

Principal Partners, Japan:

• METI, the Japan Ministry of Economy, Trade and Industry
• FujiFilm (world leader in imaging and medical devices)
• Astellas (#2 Japanese pharma)
• Many, many other Japanese companies committed to participate

Participation Fee: $2500, excluding flight, hotel and travel expenses. Companies may also pay via equity options, but at higher exchange.

Team:
Gali Einav, PhD
• Co-Founder, Vetted VC Accelerator; General Partner, Vetted VC
• Program Head, Adelson School of Entrepreneurship, Reichman University
• Professor of Entrepreneurship, Yeshiva University
• Director, Digital Research, NBC ]Universal
• Advisory Board: Nielsen Innovate Fund; Yeshiva Univ. Innovation Lab
• MA, Hebrew University; PhD, Columbia University

Levi Shapiro
• Founder and Chair, mHealth Israel (12,000+ Israeli tech ]entrepreneurs)
• Board Member: 4 startups
• Veritas Ventures, Gemini Israel Partners
• Founder, 3 startups
• MNC Experience: IBM (Europe), Toyota (Japan)
• Tulane, Cornell, MIT (MBA)

Oren Kaplan
• Meitav (Israel’s largest investment house by AUM), Member of the Board and Founder, Meitav Global Markets
• Co-Founder / CEO, Sharing Alpha (Trip Advisor for Limited Partner investors; Acquired)
• Textbook author, “Behavioral Finance”
• Dealroom manager, Bank Otsar Hahayal and Bank Hapoalim
• UCL (Economics), Tel Aviv University / Wharton (MBA)

Amir Melnikov
• Head of R&D, International Program Manager, Directorate of Defense Research & Development
• Executive Officer, MEIMAD (110m NIS venture capital fund)
• R&D and Engineering Team Leader, Israel Defense Force
• Researcher, Superconductivity and Magnetic Measurements Institute, Bar Ilan University
• Bar Ilan (Physics), Reichman (MBA), Tokyo Institute of Technology (MA, Engineering)

Mihoko Horigome (MS, MBA)
• Senior Sales Executive, Bioscience Division, Thermo Fisher, Japan
• Masters of Biology / Neuroscience, Nagoya University
• MedTech MBA, Hebrew University

To Apply: Contact Levi.Shapiro@gmail.com; +972.52.3424.149 to schedule a Zoom discussion.